| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |